Last edition
News about "Health Canada "
Health Canada Authorises Livmarli Tablet for Cholestatic Pruritus in Alagille Syndrome
Mirum Pharmaceuticals receives Health Canada approval for Livmarli tablet formulation, expanding dosing options for eligible Alagille syndrome patients with cholestatic pruritus.
Health Canada | 07/02/2026 | By News Bureau
Health Canada Grants Authorisation for Leqembi (Lecanemab)
BioArctic has the right to commercialise Leqembi in the Nordic region together with Eisai and the two companies are preparing for a joint commercialisation in the region.
Health Canada | 28/10/2025 | By Dineshwori | 175
Acclaro Medical has also partnered with Xcite Technology to spearhead commercialisation efforts across Canada.
Health Canada | 27/06/2025 | By Abha | 372
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy